Cargando…
Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment
The theranostic agent iron–quercetin complex (IronQ) provides a T1-positive magnetic resonance imaging (MRI) contrast agent. The magnetically IronQ-labeled cells can be used for cell tracking and have active biological applications in promoting cell and tissue regeneration. However, a detailed inves...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414527/ https://www.ncbi.nlm.nih.gov/pubmed/36014641 http://dx.doi.org/10.3390/nano12162776 |
_version_ | 1784776009766141952 |
---|---|
author | Dechsupa, Nathupakorn Kosintarajit, Panida Kamkan, Kanyapak Khanjina, Thanyalak Sirikul, Chonticha Innuan, Phattarawadee Suwan, Authaphinya Anukul, Nampeung Kantapan, Jiraporn |
author_facet | Dechsupa, Nathupakorn Kosintarajit, Panida Kamkan, Kanyapak Khanjina, Thanyalak Sirikul, Chonticha Innuan, Phattarawadee Suwan, Authaphinya Anukul, Nampeung Kantapan, Jiraporn |
author_sort | Dechsupa, Nathupakorn |
collection | PubMed |
description | The theranostic agent iron–quercetin complex (IronQ) provides a T1-positive magnetic resonance imaging (MRI) contrast agent. The magnetically IronQ-labeled cells can be used for cell tracking and have active biological applications in promoting cell and tissue regeneration. However, a detailed investigation of IronQ’s cytotoxicity and genotoxicity is necessary. Thus, this study aimed to evaluate the possibility of IronQ inducing cytotoxicity and genotoxicity in peripheral blood mononuclear cells (PBMCs). We evaluated the vitality of cells, the production of reactive oxygen species (ROS), the level of antioxidant enzymes, and the stability of the genetic material in PBMCs treated with IronQ. The results show that IronQ had a negligible impact on toxicological parameters such as ROS production and lipid peroxidation, indicating that it is not harmful. IronQ-labeled PMBCs experienced an insignificant depletion of antioxidant enzyme levels at the highest concentration of IronQ. There is no evident genotoxicity in the magnetically IronQ-labeled PBMCs. The results show that IronQ does not potentiate the cytotoxicity and genotoxicity effects of the labeled PMBCs and might be safe for therapeutic and cell tracking purposes. These results could provide a reference guideline for the toxicological analysis of IronQ in in vivo studies. |
format | Online Article Text |
id | pubmed-9414527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94145272022-08-27 Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment Dechsupa, Nathupakorn Kosintarajit, Panida Kamkan, Kanyapak Khanjina, Thanyalak Sirikul, Chonticha Innuan, Phattarawadee Suwan, Authaphinya Anukul, Nampeung Kantapan, Jiraporn Nanomaterials (Basel) Article The theranostic agent iron–quercetin complex (IronQ) provides a T1-positive magnetic resonance imaging (MRI) contrast agent. The magnetically IronQ-labeled cells can be used for cell tracking and have active biological applications in promoting cell and tissue regeneration. However, a detailed investigation of IronQ’s cytotoxicity and genotoxicity is necessary. Thus, this study aimed to evaluate the possibility of IronQ inducing cytotoxicity and genotoxicity in peripheral blood mononuclear cells (PBMCs). We evaluated the vitality of cells, the production of reactive oxygen species (ROS), the level of antioxidant enzymes, and the stability of the genetic material in PBMCs treated with IronQ. The results show that IronQ had a negligible impact on toxicological parameters such as ROS production and lipid peroxidation, indicating that it is not harmful. IronQ-labeled PMBCs experienced an insignificant depletion of antioxidant enzyme levels at the highest concentration of IronQ. There is no evident genotoxicity in the magnetically IronQ-labeled PBMCs. The results show that IronQ does not potentiate the cytotoxicity and genotoxicity effects of the labeled PMBCs and might be safe for therapeutic and cell tracking purposes. These results could provide a reference guideline for the toxicological analysis of IronQ in in vivo studies. MDPI 2022-08-13 /pmc/articles/PMC9414527/ /pubmed/36014641 http://dx.doi.org/10.3390/nano12162776 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dechsupa, Nathupakorn Kosintarajit, Panida Kamkan, Kanyapak Khanjina, Thanyalak Sirikul, Chonticha Innuan, Phattarawadee Suwan, Authaphinya Anukul, Nampeung Kantapan, Jiraporn Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title | Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title_full | Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title_fullStr | Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title_full_unstemmed | Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title_short | Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment |
title_sort | iron(iii)–quercetin complexes’ safety for mri cell tracking in cell therapy applications: cytotoxic and genotoxic assessment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414527/ https://www.ncbi.nlm.nih.gov/pubmed/36014641 http://dx.doi.org/10.3390/nano12162776 |
work_keys_str_mv | AT dechsupanathupakorn ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT kosintarajitpanida ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT kamkankanyapak ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT khanjinathanyalak ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT sirikulchonticha ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT innuanphattarawadee ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT suwanauthaphinya ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT anukulnampeung ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment AT kantapanjiraporn ironiiiquercetincomplexessafetyformricelltrackingincelltherapyapplicationscytotoxicandgenotoxicassessment |